Literature DB >> 18402805

Phytate inhibits bovine pericardium calcification in vitro.

Félix Grases1, Pilar Sanchis, Antonia Costa-Bauzá, Oriol Bonnin, Bernat Isern, Joan Perelló, Rafael M Prieto.   

Abstract

OBJECTIVE: The present study examined the inhibitory effects of pyrophosphate, etidronate, and phytate on bovine pericardium calcification in vitro.
METHODS: Bovine pericardium was glutaraldehyde fixed and then placed in a flow chamber in the presence of a synthetic physiological fluid alone (control) or the fluid plus various concentrations of pyrophosphate, etidronate, or phytate. Following a 96-h incubation, fragments were removed and assayed for calcification by measuring calcium and phosphorus levels.
RESULTS: The data indicated that both pyrophosphate and etidronate at 1 mg/l (5.75 and 4.95 microM, respectively) inhibited bovine pericardium calcification, whereas neither agent had an effect at 0.5 mg/l (2.87 and 2.47 microM, respectively). Phytate was the most potent inhibitor of calcification, and the effects of this agent were apparent at levels as low as 0.25 mg/l (0.39 microM).
CONCLUSIONS: While pyrophosphate, etidronate, and phytate were all able to inhibit bovine pericardium calcification in vitro, phytate was found to be the most effective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18402805     DOI: 10.1016/j.carpath.2007.08.005

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  10 in total

1.  Phytate effects on biological hydroxyapatite development.

Authors:  F Grases; O Söhnel; M Zelenková; A Rodriguez
Journal:  Urolithiasis       Date:  2015-08-13       Impact factor: 3.436

2.  Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.

Authors:  Joan Perelló; Miquel D Ferrer; Maria Del Mar Pérez; Nadine Kaesler; Vincent M Brandenburg; Geert J Behets; Patrick C D'Haese; Rekha Garg; Bernat Isern; Alex Gold; Myles Wolf; Carolina Salcedo
Journal:  Br J Pharmacol       Date:  2020-08-23       Impact factor: 8.739

3.  Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.

Authors:  Angel A López-González; Félix Grases; Nieves Monroy; Bartolome Marí; Ma Teófila Vicente-Herrero; Fernando Tur; Joan Perelló
Journal:  Eur J Nutr       Date:  2012-05-22       Impact factor: 5.614

4.  A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Authors:  Carolina Salcedo; Pieter H Joubert; Miguel D Ferrer; Ana Z Canals; Francisco Maduell; Vicens Torregrosa; Josep Maria Campistol; Raquel Ojeda; Joan Perelló
Journal:  Br J Clin Pharmacol       Date:  2019-02-19       Impact factor: 4.335

Review 5.  On the Mechanics of Transcatheter Aortic Valve Replacement.

Authors:  Lakshmi P Dasi; Hoda Hatoum; Arash Kheradvar; Ramin Zareian; S Hamed Alavi; Wei Sun; Caitlin Martin; Thuy Pham; Qian Wang; Prem A Midha; Vrishank Raghav; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2016-11-21       Impact factor: 3.934

6.  Dietary fibre and phytate--a balancing act: results from three time points in a British birth cohort.

Authors:  Celia J Prynne; Aine McCarron; Michael E J Wadsworth; Alison M Stephen
Journal:  Br J Nutr       Date:  2009-10-13       Impact factor: 3.718

7.  Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.

Authors:  Rafael M Prieto; M Fiol; J Perello; R Estruch; E Ros; P Sanchis; F Grases
Journal:  Eur J Nutr       Date:  2010-01-28       Impact factor: 5.614

8.  Urinary phytate concentration and risk of fracture determined by the FRAX indexzzm321990in a group of postmenopausal women

Authors:  Angel Arturo Lopez Gonzalez; Felix Grases; Bartolome Mari; Matias Tomas-Salva; Adrian Rodriguez
Journal:  Turk J Med Sci       Date:  2019-04-18       Impact factor: 0.973

9.  A novel assay to measure calcification propensity: from laboratory to humans.

Authors:  M Mar Perez; Miguel D Ferrer; Marta Lazo-Rodriguez; Ana Zeralda Canals; Elisenda Banon-Maneus; Josep M Campistol; Stephan Miller; Rekha Garg; Alex Gold; Carolina Salcedo; Joan Perelló
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

10.  Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Authors:  María del Mar Arriero; Joana M Ramis; Joan Perelló; Marta Monjo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.